Phase 2 Endometrial Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• Women who have been diagnosed with endometrial cancer and are scheduled for a procedure called UAE (uterine artery embolization)
• Women who are over 18 years of age
• Women who could potentially become pregnant must have a negative pregnancy test result before joining
• People who are awake, aware, and able to follow the study procedures
• People who have read and signed the consent form approved by the ethics review board

Who may not be able to join:

• Women who are currently pregnant or breastfeeding
• People who have taken part in another experimental drug study within the 30 days before the study drug is given, or who will do so within 72 hours after
• People who are medically unstable, seriously or terminally ill, or whose medical condition is unpredictable — for example, people on life support, in a critical care unit, those with unstable heart rhythm problems (such as recurring dangerous heart rhythms), or those who have recently had bleeding in the brain
• People who have had surgery within the 24 hours before the study's ultrasound examination
• People who were born with a heart defect
• People who have a known allergy to a substance called Definity (an ultrasound contrast agent used in the study)

Important: Always verify eligibility with the trial site directly before applying.